309 results
Page 12 of 16
8-K
EX-99.1
hq7796wv9h9xy5c27
9 Jun 11
Complete sequencing of DNA shows normality of the cells and their suitability for clinical use
12:00am
8-K
EX-99.1
13k auwrltt3q
3 Jun 11
BioTime Receives NIH Approval for Two GMP Human Embryonic Stem Cell Lines
12:00am
DEFA14A
wa4c 3fmbtrjapwviv
24 May 11
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
lgpp04h0kesrk5
10 May 11
BioTime Announces Issuance of U.S. Glycosan Hydrogel Patent
12:00am
8-K
EX-99.1
7etmwb kxrnq1d
5 May 11
BioTime Announces First Quarter 2011 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
lswr180j10
3 May 11
BioTime Initiates Clinical Development Program for HyStem®-Rx as a Cell Delivery Device for Reconstructive Surgery and Other Cell-Based Therapies
12:00am
8-K
EX-99.1
8b0lh6nvzqr99x8fmpk
12 Apr 11
BioTime Presents Data at FABS 2011 on the Restoration of Cell Lifespan Using iPS Cell Technology
12:00am
8-K
EX-99.1
k9c6q0v575b25
6 Apr 11
BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine
12:00am
8-K
EX-99.1
s9dd34yj7ziye6q8bk
22 Mar 11
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
12:00am
8-K
EX-99.1
fi53 u41ca3
15 Mar 11
BioTime Announces Fourth Quarter and Fiscal Year 2010 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
7cwa4j7l5h
4 Mar 11
Update on ReCyte™ technology for resetting telomere length and its application in cardiovascular disease
12:00am
8-K
EX-99.1
iw95h5u
14 Feb 11
BioTime Announces Agreement To Acquire Glycosan BioSystems
12:00am
8-K
EX-99.1
vyjvu4q
28 Jan 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
t2r vlz1qv48lm2
10 Jan 11
BioTime’s CEO Michael West to Present Preclinical Data on OTX-CP03 and OTX-CP07 for the Treatment of Osteoarthritis at STEM 2011 in Gurgaon, India
12:00am
8-K
EX-99.1
xss7kd
3 Jan 11
BioTime Subsidiary ReCyte Therapeutics, Inc. to Develop Therapies for Age-Related Cardiovascular and Blood Disorders
12:00am
8-K
EX-99.1
ubktq6zy 0qz5l46
22 Dec 10
BioTime, Inc. and the University of California System Sign Cell Transfer Agreement for Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
5uz56mqbuo8611ntjr
9 Dec 10
BioTime Asia, Limited and Shanghai Genext Medical Technology Co., Ltd. Sign Marketing Agreement for ACTCellerate™ Cell Lines
12:00am
8-K
EX-99.1
e1oi6w8qrva 0egr4mm
3 Dec 10
Other Events
12:00am
8-K
EX-99.1
4c9jj
29 Nov 10
BioTime, Inc. and the California Institute for Regenerative Medicine Sign Distribution Agreement for GMP-Compliant Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
3kblgv
10 Nov 10
Other Events
12:00am